EU approves Sanofi's 6-in-1 vaccine for infants

04/22/2013 | Reuters · Fox Business

The European Commission has cleared Sanofi's 6-in-1 pediatric vaccine for infants starting at six weeks. The vaccine prevents hepatitis B, poliomyelitis, diphtheria, tetanus, pertussis and invasive infections caused by Haemophilus influenzae type B. The vaccine will be sold as Hexyon in Western Europe and as Hexacima in Eastern Europe.

View Full Article in:

Reuters · Fox Business

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY